rotaviru
common
caus
sever
diarrhea
infant
children
develop
develop
countri
worldwid
global
rotaviru
gastroenter
caus
death
half
million
children
younger
year
age
ill
creat
diseas
burden
virtual
societi
around
world
rotavirus
includ
genu
rotaviru
part
reovirida
famili
neg
contrast
electron
microscopi
reveal
viral
particl
take
wheellik
appear
fece
lead
prefix
rota
rotaviru
particl
larg
size
nonenvelop
three
concentr
layer
protein
surround
viral
genom
genom
compris
segment
doublestrand
rna
characterist
allow
reassort
natur
infect
yield
new
strain
segment
encod
six
structur
viral
protein
vp
form
viru
particl
six
nonstructur
protein
nsp
nsp
synthes
infect
cell
interact
host
protein
influenc
pathogenesi
immun
respons
infect
rotaviru
outer
capsid
shell
made
protein
spikelik
project
protrud
capsid
shell
form
glycoprotein
threelay
capsid
render
stabl
resist
acid
ph
stomach
digest
enzym
small
intestin
eas
fecalor
transmiss
deliveri
viru
small
intestin
rotaviru
caus
patholog
chang
structur
function
rotavirus
classifi
group
ae
accord
antigen
group
major
capsid
antigen
group
b
c
shown
infect
human
group
caus
preponder
human
rotavir
gastrointestin
diseas
rotavirus
classifi
g
p
type
base
identif
antigen
outer
capsid
protein
sever
infect
young
children
caus
serotyp
gener
dens
popul
countri
show
complex
pattern
serotyp
preval
last
two
decad
infect
appear
predomin
global
worldwid
approxim
hospit
diarrhea
children
younger
year
age
attribut
rotaviru
infect
viru
identifi
stool
children
admit
acut
diarrhea
develop
countri
develop
countri
children
younger
year
age
die
annual
rotaviru
death
occur
african
asian
nation
unit
state
prior
vaccin
introduct
rotaviru
infect
account
doctor
visit
emerg
room
visit
hospit
death
per
year
cost
amount
billion
yearli
see
fig
rotaviru
diseas
burden
virtual
children
infect
rotaviru
age
variou
degre
sever
common
progress
less
sever
subsequ
rotaviru
infect
caus
boost
mucos
immun
seriou
rotaviru
infect
occur
often
children
month
age
neonat
infect
often
asymptomat
healthi
fullterm
infant
presum
due
passiv
immun
transplacent
breastmilk
antibodi
adult
rare
sever
affect
roughli
adult
household
contact
infect
infant
may
develop
symptomat
diseas
rotaviru
gastroenter
season
variat
pattern
unit
state
countri
temper
climat
infect
predomin
winter
month
annual
epidem
occur
decemb
june
region
variat
also
exist
within
particular
climat
countri
exampl
unit
state
rotaviru
season
start
southwest
fall
end
northeast
spring
europ
season
begin
southern
region
spread
north
fall
spring
month
rotaviru
infect
fluctuat
less
tropic
though
recent
systemat
review
studi
tropic
area
conclud
infect
promin
coolest
driest
month
year
rotaviru
primarili
transmit
persontoperson
via
fecalor
rout
develop
region
may
also
spread
via
fecal
contamin
water
infect
individu
usual
shed
larg
quantiti
viru
particl
per
gram
stool
ten
viral
particl
may
caus
infect
patient
viral
shed
may
occur
day
prior
initi
symptom
continu
averag
day
though
shed
report
day
immunocompet
patient
immunocompromis
patient
may
excret
viru
even
longer
period
viru
may
surviv
least
h
hand
day
week
environment
surfac
week
drink
water
transmiss
increas
set
child
daycar
center
famili
home
diaper
chang
identifi
highestrisk
activ
addit
rotaviru
found
toy
faucet
handwash
area
even
food
prepar
area
indic
fomit
may
play
role
viral
transmiss
high
infect
presymptomat
shed
prolong
environment
life
span
import
factor
transmiss
rotaviru
transmiss
anim
human
rare
evid
howev
anim
rotavirus
infect
human
via
direct
transmiss
viru
contribut
one
rna
segment
reassort
human
strain
respiratori
spread
rotaviru
via
aerosol
particl
also
suggest
rotaviru
detect
respiratori
secret
small
number
patient
case
pneumonia
describ
rotaviru
rna
air
sampl
taken
room
hospit
children
rotaviru
gastroenter
indic
airborn
spread
may
rout
transmiss
rotaviru
especi
hospit
daycar
set
rotaviru
profound
effect
gastrointestin
tract
yet
system
infect
report
rna
protein
rotaviru
frequent
detect
blood
infect
children
well
liver
heart
lung
central
nervou
system
rotaviru
particl
ingest
oral
small
intestin
spike
capsid
surfac
may
proteolyz
enzym
trypsin
cleavag
caus
conform
chang
spike
structur
expos
attach
site
surfac
glycoprotein
viru
attach
host
receptor
enterocyt
entri
process
begin
outer
capsid
shell
remov
doublelay
particl
insert
cytoplasm
particl
produc
cap
viral
messeng
rna
mrna
displac
transcrib
particl
cell
cytoplasm
translat
protein
replic
new
genom
rna
viral
replic
process
uniqu
occur
viroplasm
electrondens
structur
near
cell
nucleu
endoplasm
reticulum
newli
assembl
particl
newli
replic
dsrna
bud
endoplasm
reticulum
viroplasm
equip
outer
capsid
protein
fulli
develop
viru
particl
releas
enterocyt
via
cell
lysi
deliveri
particl
apic
plasma
membran
cell
rotaviru
primarili
invad
matur
enterocyt
villi
spare
intestin
crypt
enterocyt
destruct
fluid
move
intestin
lumen
result
net
loss
fluid
electrolyt
stool
malabsorpt
occur
secondari
loss
absorpt
enterocyt
decreas
synthesi
lactas
digest
enzym
alter
tight
junction
enterocyt
lead
paracellular
leakag
rotaviru
toxin
nonstructur
glycoprotein
may
contribut
pathophysiolog
induc
secretori
compon
diarrhea
viral
enterotoxin
report
increas
intracellular
calcium
activ
cellular
chlorid
channel
turn
increas
secret
chlorid
consequ
water
lumen
also
found
activ
secretori
reflex
enter
nervou
system
en
contribut
diarrhea
microischemia
villi
impair
polar
transport
sucraseisomaltas
membran
surfac
neuron
mediat
intestin
hypersecret
alter
intestin
motil
possibl
mechan
rotaviru
injuri
histolog
rotaviru
associ
wide
spectrum
chang
rang
virtual
normal
mucosa
mild
enterocyt
vacuol
loss
signific
villou
blunt
crypt
hyperplasia
degre
inflamm
usual
milder
caus
intestin
pathogen
appear
direct
correl
histolog
find
diseas
symptom
day
incub
period
symptom
often
start
abruptli
vomit
follow
wateri
diarrhea
noninflammatori
process
blood
white
cell
typic
absent
stool
onethird
patient
fever
c
report
clinic
featur
acut
rotavir
infect
includ
anorexia
lethargi
abdomin
cramp
less
common
diarrhea
rang
mild
sever
result
dehydr
shock
electrolyt
imbal
even
death
sever
dehydr
rotaviru
infect
occur
mostli
children
age
month
rotaviru
gener
selflimit
viru
vomit
settl
within
h
diarrhea
day
studi
note
respiratori
symptom
otiti
media
half
patient
rotaviru
infect
intussuscept
rotaviru
infect
may
caus
disturb
motil
gastrointestin
tract
acut
infect
oppos
typic
lead
point
lipopolysaccharid
may
slow
intestin
motil
induct
variou
inflammatori
agent
prostaglandin
cytokin
nitric
oxid
center
diseas
control
prevent
cdc
defin
confirm
case
rotaviru
gastroenter
diarrhea
loos
stool
within
h
vomit
episod
h
period
child
posit
stool
detect
rotaviru
standard
assay
enzym
immunoassay
eia
confirm
rotaviru
infect
necessari
reliabl
surveil
clinic
use
avoid
inappropri
antimicrobi
use
wide
use
method
detect
rotaviru
antigen
stool
eia
assay
typic
detect
rotaviru
group
antigen
present
mani
eia
kit
commerci
avail
provid
rapid
inexpens
result
sensit
strain
may
character
addit
enzym
immunoassay
revers
transcriptas
polymeras
chain
reaction
rtpcr
research
center
use
techniqu
detect
surveil
rotaviru
includ
electron
microscopi
rtpcr
nucleic
acid
hybrid
sequenc
analysi
cultur
techniqu
labor
intens
provid
littl
addit
clinic
util
nonbloodi
wateri
diarrhea
rotaviru
gastroenter
clinic
indistinguish
caus
enter
virus
includ
noroviru
calicivirus
enter
adenoviru
astroviru
said
rotaviru
associ
acut
diarrhea
may
sever
frequent
associ
fever
vomit
presenc
blood
leukocyt
stool
suggest
altern
diagnos
includ
bacteri
etiolog
salmonella
shigella
yersinia
campylobact
escherichia
coli
noninfecti
etiolog
includ
intussuscept
must
also
consid
infant
present
protozo
infect
particularli
entamoeba
histolytica
giardia
lamblia
cryptosporidium
parvum
also
includ
differenti
diagnosi
mention
rotaviru
infect
frequent
selflimit
cessat
vomit
within
day
diarrhea
within
day
sever
dehydr
infect
occur
often
young
children
age
month
malnutrit
known
increas
sever
infect
delay
small
intestin
recoveri
alter
inflammatori
respons
acut
complic
includ
dehydr
sodium
imbal
possibl
seizur
rey
syndrom
enceph
rectal
bleed
intussuscept
associ
rotaviru
evid
show
caus
effect
lack
rotaviru
gastroenter
gener
selflimit
ill
treatment
larg
support
initi
manag
focu
identif
correct
underli
fluid
electrolyt
imbal
assess
dehydr
use
oral
rehydr
therapi
critic
review
elsewher
text
chap
acut
gastroenter
infant
children
undernourish
children
particularli
risk
sever
andor
persist
symptom
great
care
must
taken
encourag
earli
resumpt
normal
feed
typic
includ
breastfeed
role
antibiot
treatment
rotaviru
gastroenter
use
antiemet
antidiarrh
gener
avoid
pleas
see
chap
acut
gastroenter
infant
children
detail
oral
administr
probiot
lactobacillu
gg
effect
reduc
viral
shed
shorten
symptom
durat
roughli
day
improv
notabl
probiot
given
earli
cours
ill
seem
promin
young
children
mechan
may
due
enhanc
immun
respons
viru
oral
administ
human
immun
globulin
investig
therapi
immunocompromis
patient
found
shorten
cours
diarrhea
decreas
viral
excret
investig
requir
costbenefit
ratio
may
justifi
usag
therapi
widescal
basi
rotaviru
attack
rate
similar
develop
develop
region
suggest
improv
sanit
unlik
play
signific
part
diseas
prevent
high
infect
viru
make
control
measur
difficult
rotavirus
rel
resist
chemic
disinfect
use
wide
hospit
effect
agent
includ
chlorhexidin
glucon
quaternari
ammonium
compound
high
alcohol
content
hand
wash
plain
soap
often
ineffect
rotaviru
may
even
spread
viru
larger
area
hand
use
waterless
alcoholbas
handclean
agent
patient
contact
recommend
breastfeed
play
protect
role
acquir
rotaviru
may
due
presenc
antirotavir
secretori
iga
trypsin
inhibitor
breast
milk
breastf
infant
also
excret
fewer
virus
formulaf
infant
base
upon
signific
morbid
mortal
childhood
rotavir
infect
worldwid
great
attent
focus
upon
develop
success
vaccin
sinc
multipl
candid
vaccin
tri
initi
vaccin
base
upon
use
anim
rotaviru
strain
pathogen
human
fail
provid
suffici
clinic
protect
rotashield
wyethlederl
vaccin
philadelphia
pa
tetraval
simianhuman
reassort
rotaviru
vaccin
licens
fda
base
upon
data
show
protect
dehydr
rotaviru
diarrhea
within
month
releas
cdc
vaccin
advers
event
report
system
vaer
report
case
intussuscept
infant
receiv
vaccin
subsequ
case
control
retrospect
cohort
studi
verifi
tempor
associ
rel
risk
intussuscept
within
week
follow
first
vaccin
dose
exceed
studi
prompt
vaccin
withdraw
market
two
subsequ
oral
rotaviru
vaccin
licens
mani
nation
around
world
includ
unit
state
vaccin
led
declin
rotavir
infect
mortal
worldwid
glaxosmithklin
biolog
rixensart
belgium
base
live
attenu
human
rotaviru
strain
merck
co
inc
whitehous
station
nj
usa
pentaval
humanbovin
reassort
low
rate
replic
human
gastrointestin
tract
low
rate
fecal
shed
larg
phase
iii
clinic
trial
demonstr
well
toler
also
demonstr
immunogen
highli
efficaci
prevent
case
rotaviru
gastroenter
greater
associ
sever
diarrhea
africa
asia
rotaviru
associ
death
occur
vaccin
reduc
case
sever
rotaviru
diarrhea
greater
first
year
life
diseas
burden
mortal
greatest
world
health
organ
strateg
advisori
group
expert
declar
rotaviru
vaccin
includ
nation
immun
program
worldwid
particularli
nation
high
diarrheal
fatal
diarrheaassoci
death
develop
countri
could
reduc
vaccin
recommend
given
threedos
seri
infant
age
week
vaccin
recommend
administ
twodos
seri
age
month
detail
vaccin
schedul
provid
tabl
contraind
rotaviru
vaccin
includ
previou
sever
lifethreaten
allerg
reaction
compon
vaccin
immunocompromis
state
data
cdc
vaer
shown
observ
rate
intussuscept
children
higher
ageadjust
background
rate
intussuscept
similarli
studi
show
increas
risk
kawasaki
syndrom
administr
vaccin
sinc
introduct
vaccin
incid
rotaviru
diarrhea
infant
dramat
decreas
one
studi
note
nearli
hospit
gastroenter
patient
younger
year
age
test
posit
rotaviru
stool
three
season
vaccin
introduct
percentag
drop
result
declin
studi
termin
furthermor
rotaviru
season
found
shorten
delay
see
fig
hospit
children
due
laboratoryconfirm
rotaviru
gastroenter
newer
approach
nonrepl
viruslik
particl
vlp
vaccin
present
evalu
meanwhil
current
rotaviru
vaccin
remain
success
decreas
morbid
mortal
global
health
diseas
norwalk
viru
carri
histor
import
first
confirm
viral
etiolog
human
gastroenter
identifi
electron
microscopi
stool
sever
outbreak
diarrhea
norwalk
ohio
subsequ
similar
appear
virus
often
call
norwalklik
virus
recent
reclassif
defin
famili
calicivirida
nm
nonenvelop
singlestrand
rna
virus
within
famili
four
distinct
genera
noroviru
genu
account
roughli
calicivirusassoci
gastroenter
discuss
greater
detail
three
genera
sapoviru
lagoviru
vesiviru
less
clinic
relev
human
noroviru
strain
classifi
sever
distinct
genogroup
subgroup
genogroup
ii
identifi
common
strain
infect
human
worldwid
new
pandem
strain
emerg
everi
year
norovirus
common
caus
nonbacteri
gastroenter
outbreak
worldwid
infect
may
occur
year
round
though
case
report
winter
month
children
adult
affect
center
diseas
control
cdc
estim
norovirus
caus
million
case
gastrointestin
ill
annual
unit
state
account
half
foodborn
diseas
outbreak
noroviru
infect
lead
estim
hospit
death
annual
unit
state
rotaviru
lead
hospit
gastroenter
children
develop
countri
noroviru
also
common
etiolog
diarrhea
india
peru
respect
stool
sampl
hospit
pediatr
gastroenter
patient
test
posit
noroviru
via
pcr
tabl
given
month
age
rotaviru
noroand
calicivirus
noroviru
outbreak
frequent
occur
close
environ
cruis
ship
camp
nurs
home
school
typic
outbreak
origin
direct
contamin
infect
food
handler
food
contamin
sourc
oyster
contamin
water
also
describ
virus
highli
contagi
outbreak
explos
potenti
thousand
peopl
infect
short
period
time
noroviru
typic
transmit
via
fecalor
rout
ingest
contamin
food
water
addit
vomitu
shown
contain
infecti
particl
virion
requir
infect
expos
roughli
individu
may
shed
viru
prior
onset
symptom
viral
shed
peak
day
ill
develop
may
persist
week
viru
stabl
freez
temperatur
c
factor
contribut
eas
spread
potenti
larg
outbreak
incub
period
rang
h
diseas
onset
quit
rapid
vomit
nonbloodi
wateri
diarrhea
fever
occur
roughli
case
constitut
symptom
headach
myalgia
chill
common
onethird
patient
ill
often
mild
shortliv
patient
experienc
less
day
vomit
diarrhea
risk
dehydr
requir
hospit
greatest
children
less
year
age
adult
year
older
infect
host
proxim
duodenum
demonstr
villou
broaden
blunt
cryptcel
hyperplasia
cytoplasm
vacuol
inflammatori
cell
infiltr
lamina
propria
histolog
stomach
colon
spare
intestin
brush
border
enzym
diminish
acut
infect
result
carbohydr
malabsorpt
mild
steatorrhea
also
note
promin
nausea
vomit
associ
noroviru
gastroenter
may
relat
delay
gastric
empti
document
symptomat
adult
preponder
vomit
high
attack
rate
across
age
group
characterist
featur
caliciviru
gastroenter
noroviru
outbreak
distinguish
caus
preform
toxin
slightli
longer
incub
period
h
vs
h
toxin
emerg
secondari
case
household
contact
gener
caliciviru
infect
tend
milder
less
dehydr
cours
rotaviru
said
ill
reliabl
clinic
distinguish
caus
enter
virus
includ
rotaviru
enter
coronaviru
enter
adenoviru
astroviru
human
norovirus
cultur
revers
transcriptas
polymeras
chain
reaction
rtpcr
use
detect
viral
rna
stool
emesi
sampl
addit
environment
swab
food
water
special
circumst
techniqu
challeng
human
calicivirus
genet
divers
consequ
sever
set
primer
must
use
confirm
infect
realtim
quantit
rtpcr
assay
increas
sensit
specif
diagnost
modal
rtpcr
detect
avail
public
health
research
laboratori
readili
commerci
avail
area
enzym
immun
assay
eia
noroviru
detect
approv
commerci
use
countri
though
poor
sensit
current
assay
limit
use
sporad
case
outbreak
situat
howev
use
rapidli
identifi
noroviru
caus
agent
mani
situat
microbiolog
confirm
suspect
noroviru
outbreak
possibl
kaplan
criteria
develop
distinguish
outbreak
caus
noroviru
caus
bacteri
etiolog
criteria
vomit
greater
affect
person
mean
ill
durat
h
mean
incub
period
h
bacteri
pathogen
identifi
stool
cultur
highli
specif
moder
sensit
regard
roughli
norovirusinduc
outbreak
satisfi
four
criteria
still
import
consid
viru
appropri
clinic
set
noroviru
diagnost
test
becom
wide
avail
applic
criteria
may
use
diagnost
aid
identifi
foodborn
gastroenter
outbreak
due
noroviru
note
caliciviru
gastroenter
gener
fairli
mild
selflimit
immunocompromis
host
infant
elderli
highest
risk
protract
ill
sever
dehydr
report
arisen
suggest
associ
noroviru
necrot
enterocol
newborn
benign
seizur
infant
inflammatori
bowel
diseas
exacerb
pediatr
patient
studi
requir
investig
possibl
link
specif
treatment
avail
caus
viral
gastroenter
support
care
attent
fluid
electrolyt
balanc
crucial
pleas
see
chap
acut
gastroenter
infant
children
addit
detail
outbreak
prevent
secondari
spread
import
halt
progress
enforc
person
hygien
use
contact
precaut
decontamin
environment
surfac
use
rotaviru
noroand
calicivirus
alcoholbas
hand
sanit
found
decreas
spread
infect
peopl
diarrhea
due
noroviru
refrain
refrain
use
recreat
water
venu
pool
lake
least
week
follow
resolut
symptom
develop
effect
prevent
measur
great
interest
given
signific
socioeconom
burden
larg
prolong
outbreak
contrast
rotaviru
human
acquir
longterm
immun
noroviru
infect
make
vaccin
develop
challeng
viruslik
particl
vaccin
current
evalu
